ANDRES GUTIERREZ
Profile
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
DIRECTOR
EXECUTIVE OFFICER
RONI APPEL, RONI A. APPEL, KEN A. BERLIN, KENNETH BERLIN, RICHARD BERMAN, VERED BISKER-LEIB, YUVAL CABILLY, FREDRICK COBB, IGOR GITELMAN, ROY GOLAN, MURRAY A. GOLDBERG, SAMIR KHLEIF, BRIDGET MARTELL, THOMAS MCKEARN, THOMAS L. MCKEARN, THOMAS MOORE, THOMAS A. MOORE, PINI ORBACH, JAMES PATTON, MARK J. ROSENBLUM, JOHN ROTHMAN, JOHN M. ROTHMAN, DAVID SIDRANSKY, ROBERT SPIEGEL
EXECUTIVE OFFICER, DIRECTOR
EXECUTIVE OFFICER
RONI APPEL, RONI A. APPEL, KEN A. BERLIN, KENNETH BERLIN, RICHARD BERMAN, VERED BISKER-LEIB, YUVAL CABILLY, FREDRICK COBB, IGOR GITELMAN, ROY GOLAN, MURRAY A. GOLDBERG, SAMIR KHLEIF, BRIDGET MARTELL, THOMAS MCKEARN, THOMAS L. MCKEARN, THOMAS MOORE, THOMAS A. MOORE, PINI ORBACH, JAMES PATTON, MARK J. ROSENBLUM, JOHN ROTHMAN, JOHN M. ROTHMAN, DAVID SIDRANSKY, ROBERT SPIEGEL
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2023-10-18
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
$1,000,001 - $5,000,000
Equity
2022-01-31
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
$1,000,001 - $5,000,000
2021-04-14

